Medartis Holding AG
SIX:MED

Watchlist Manager
Medartis Holding AG Logo
Medartis Holding AG
SIX:MED
Watchlist
Price: 51.2 CHF -5.88%
Market Cap: 696.1m CHF
Have any thoughts about
Medartis Holding AG?
Write Note

Medartis Holding AG
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medartis Holding AG
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Medartis Holding AG
SIX:MED
Cash from Investing Activities
-CHf24.6m
CAGR 3-Years
-5%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Alcon AG
SIX:ALC
Cash from Investing Activities
-$1.1B
CAGR 3-Years
-24%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Coltene Holding AG
SIX:CLTN
Cash from Investing Activities
-CHf7.4m
CAGR 3-Years
10%
CAGR 5-Years
42%
CAGR 10-Years
N/A
Ypsomed Holding AG
SIX:YPSN
Cash from Investing Activities
-CHf234.2m
CAGR 3-Years
-26%
CAGR 5-Years
-15%
CAGR 10-Years
-22%
IVF Hartmann Holding AG
SIX:VBSN
Cash from Investing Activities
CHf23.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medartis Holding AG
Glance View

Market Cap
695.3m CHF
Industry
Health Care

Medartis Holding AG operates as a medical device company. The company is headquartered in Basel, Basel-Stadt and currently employs 684 full-time employees. The company went IPO on 2018-03-23. The Group develops, manufactures and distributes to surgeons, hospitals and medical centers titanium screws, plates, surgical instruments and system solutions for internal fracture fixation. Medartis AG, the Company's wholly-owned subsidiary, has developed such technologies as TriLock for locking the screw into the plate, SpeedTip, a screw that does not require pre-drilling, and HexaDrive self-holding screw and screw-driver. The company has two product lines. The APTUS product line comprises upper and lower extremities products for hand, wrist, elbow, shoulder and foot fixation. The MODUS line combines products dedicated to cranio-maxillofacial (CMF) surgery. The Group's products are sold globally in more than 30 countries, including Germany and the United States, either directly through its sales subsidiaries, or through third-party distributors.

MED Intrinsic Value
80.96 CHF
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Medartis Holding AG's Cash from Investing Activities?
Cash from Investing Activities
-24.6m CHF

Based on the financial report for Jun 30, 2024, Medartis Holding AG's Cash from Investing Activities amounts to -24.6m CHF.

What is Medartis Holding AG's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-7%

Over the last year, the Cash from Investing Activities growth was 36%. The average annual Cash from Investing Activities growth rates for Medartis Holding AG have been -5% over the past three years , -7% over the past five years .

Back to Top